Differential citation rates of major cardiovascular clinical trials according to source of funding a survey from 2000 to 2005

Circulation

Volumn 118, Issue 13, 2008, Pages 1321-1327

  Conen, David ^a   Torres, Jose ^a   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bibliometrics; Cardiovascular diseases; Financial support; Organizations, nonprofit; Randomized controlled trials as topic

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CITATION ANALYSIS; CLINICAL RESEARCH; CLINICAL TRIAL; CORONARY STENT; FUNDING; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH SURVEY; HEART FAILURE; HEART PACING; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; RESTENOSIS; BIBLIOMETRICS; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; ECONOMICS; FINANCIAL MANAGEMENT; HOSPITAL; INFORMATION PROCESSING; NON PROFIT HOSPITAL; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TREATMENT OUTCOME;

BIBLIOMETRICS; CARDIOVASCULAR DISEASES; DATA COLLECTION; HOSPITALS, PROPRIETARY; HOSPITALS, VOLUNTARY; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUPPORT AS TOPIC; TREATMENT OUTCOME;

EID: 54049122166     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.794016     Document Type: Article

References (27)

1. Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. JAMA. 2006;295:2270-2274.
2. Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, Schreiber W, Unger G, Glogar HD, Kaff A, Laggner AN, Maurer G, Mlczoch J, Slany J, Weber HS, Huber K. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation. 2006;113:2398-2405.
3. Garfield E. How can impact factors be improved? BMJ. 1996;313:411-413.
4. Callaham M, Wears RL, Weber E. Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA. 2002;287:2847-2850.
5. Kulkarni AV, Busse JW, Shams I. Characteristics associated with citation rate of the medical literature. PLoS ONE. 2007;2:e403.
6. Patsopoulos NA, Analatos AA, Ioannidis JP. Relative citation impact of various study designs in the health sciences. JAMA. 2005;293:2362-2366.
7. Garfield E. The history and meaning of the journal impact factor. JAMA. 2006;295:90-93.
8. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Wong SC, Fish D, Ellis S, Holmes DR, Kerieakes D, Kuntz RE. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 2001;344:250-256.
9. Verin V, Popowski Y, de Bruyne B, Baumgart D, Sauerwein W, Lins M, Kovacs G, Thomas M, Calman F, Disco C, Serruys PW, Wijns W. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty: the Dose-Finding Study Group. N Engl J Med. 2001;344:243-249.
10. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M. Trupp RJ. Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
11. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, McAnulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes NA 3rd, Greenspon A, Goldman L. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002;346:1854-1862.
12. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
13. Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344:1659-1667.
14. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J. Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet. 2004;364:911-912.
15. Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005;353:2779-2787.
16. Steinbrook R. Public access to NIH-funded research. N Engl J Med. 2005;352:1739-1741.
17. Eysenbach G. Citation advantage of open access articles. PLoS Biol. 2006;4:e157.
18. Patsopoulos NA, Ioannidis JP, Analatos AA. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ. 2006;332:1061-1064.
19. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356:1742-1750.
20. Phillips DP, Kanter EJ, Bednarczyk B, Tastad PL. Importance of the lay press in the transmission of medical knowledge to the scientific community. N Engl J Med. 1991;325:1180-1183.
21. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA. 2008;299:1800-1812.
22. Bero LA, Galbraith A, Rennie D. The publication of sponsored symposiums in medical journals. N Engl J Med. 1992;327:1135-1140.
23. Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA. 1994;272:108-113.
24. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454-465.
25. Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med. 2007;4:e5.
26. Yank V, Rennie D, Bero LA. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. BMJ. 2007;335:1202-1205.
27. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.